This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Peptron Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Ju-Han Lee: Innovator in Controlled-Release Technology
Introduction
Ju-Han Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of controlled-release drug delivery systems. His innovative work focuses on enhancing the bioavailability and effectiveness of therapeutic agents.
Latest Patents
Ju-Han Lee holds a patent for a composition and microsphere for the controlled release of exendin. This patent describes a controlled-release composition that includes exendin as an active ingredient, a biodegradable polymer with specific viscosity, and coating materials. The invention aims to provide high bioavailability while ensuring a sustained release of the active ingredient without an excessive initial burst. The controlled-release microspheres consist of a core that includes exendin and a biodegradable polymer, along with a coating layer. The method of preparing these microspheres involves mixing exendin, a biodegradable polymer, and a solvent, followed by the removal of the solvent to create hardened microspheres.
Career Highlights
Ju-Han Lee is associated with Peptron Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in the development of innovative drug delivery systems that improve patient outcomes.
Collaborations
Ju-Han Lee collaborates with talented individuals such as Chae-Jin Lim and Mi-Jin Baek, who contribute to his research initiatives. Their combined expertise enhances the potential for groundbreaking advancements in the field.
Conclusion
Ju-Han Lee's contributions to controlled-release technology exemplify the importance of innovation in the pharmaceutical industry. His work not only advances scientific knowledge but also has the potential to improve therapeutic outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile